Cinterion Launches M2M Solution with Oracle Java ME Embedded 3.2 for Secure Wireless Connectivity
New Cinterion EHS5 module speeds up time-to-market and seamlessly integrates data from Edge-to-Enterprise
Regulatory News:
Cinterion , Gemalto’s (Euronext NL 0000400653 GTO) machine-to-machine (M2M) business segment and the global leader in M2M communication technology, today launched EHS5 - an ultra compact, high-speed M2M communication module providing secure wireless connectivity for a wide variety of industrial applications. The new Cinterion solution features a complete client Java runtime optimized for microcontrollers and other resource-constrained devices, providing Original Equipment Manufacturers (OEMs) with a cost effective, flexible platform for bringing advanced M2M technology to market faster.
The Gemalto Cinterion EHS5 module represents a milestone in miniaturized, scalable M2M technology. Sharing the same compact footprint as Cinterion 2G products, this next-generation solution enables network migration within a single design while ensuring long-lasting, future-proof applications. The solution’s powerful Java-based application environment allows the vast Java developer community to tap into its existing resources to simplify and to speed up M2M solution design and integration. It also enables lean system architecture by running software directly on the Cinterion module eliminating the expense of additional co-processors and memory chips and making applications smaller and less complex. The module’s Java Virtual Machine (JVM) serves as a hub connecting application software with security elements and end user computer systems to greatly ease integration and deployment. In addition, it enables value added features such as over-the-air (OTA) provisioning and remote updates of data and applications, which are crucial for keeping M2M solutions current over the long life of applications, which can often exceed 10 years.
"Java technology has always been a core component of Oracle’s relationship with Cinterion and we are pleased that they have selected the Oracle implementation of Java ME to help realize their Java vision and strategy for Gemalto’s M2M segment, " said Nandini Ramani, vice president, Software Development, Java Client and Mobile Platforms, Oracle. "Java ME Embedded 3.2 delivers a new Java implementation optimized specifically for microcontrollers and small embedded devices like the Cinterion EHS5 module, helping to not only meet current customers‘ needs for reduced complexity and faster time to market, but also providing a platform for development and growth in the rapidly expanding M2M market segment of embedded systems."
“There are more than 850 million computers and billions of devices and machines currently running Java technologies, many of which being secure objects from Gemalto” said Norbert Muhrer, Senior Vice President, Gemalto Cinterion M2M segment. “The Cinterion Java modules are a dynamic link at the center of industry-specific M2M applications. They connect Java-based machines, devices and sensors at the edge of an enterprise to the backend Enterprise Resource Planning systems, sending data where it is needed most for successful and dependable business operations. Edge-to-Enterprise, or E2E, connectivity is clearly the future of M2M.”
The Cinterion EHS5 M2M Module Technical Details:
The compact
EHS5 solution measures 18.8 x 27.6 x 2.3 mm. It is available in two
variants: EHS5-US (850/1900 MHz) for North America, and EHS5-E (900/2100
MHz) assuring global coverage.
About Oracle
Oracle engineers hardware and software to work
together in the cloud and in your data center. For more information
about Oracle (NASDAQ:ORCL), visit http://www.oracle.com
.
About Cinterion, a Gemalto Company
Cinterion, the
Machine-to-Machine (M2M) segment of Gemalto (Euronext NL 0000400653
GTO), is the industry pioneer for wireless M2M communication and market
leader for more than 15 years. Cinterion enables businesses to succeed
in a complex M2M ecosystem by offering expertise, security, simplicity
and partnership. Cinterion’s award-winning products and services connect
people, machines, equipment and vehicles over wireless networks, helping
enterprises simplify operations, increase efficiency and establish new
business models. Equipment makers, integrators, MNOs, and end-users rely
on Cinterion for leading-edge wireless M2M communication modules,
Machine Identification Modules (MIMs), MIM personalization capabilities
plus a trusted and secure, cloud-based Service Delivery Platform for any
M2M application. Cinterion powers cellular communications for:
telematics and automotive applications, tracking and tracing, industrial
mobile computing, metering and smart grid, payment systems, healthcare,
security systems, routers and gateways, remote maintenance and control
and more.
About Gemalto
Gemalto (Euronext NL0000400653 GTO) is the world leader in digital security with 2011 annual revenues of €2 billion and more than 10,000 employees operating out of 74 offices and 14 Research & Development centers, located in 43 countries.
We are at the heart of the rapidly evolving digital society. Billions of people worldwide increasingly want the freedom to communicate, travel, shop, bank, entertain and work – anytime, everywhere – in ways that are enjoyable and safe. Gemalto delivers on their expanding needs for personal mobile services, payment security, authenticated cloud access, identity and privacy protection, eHealthcare and eGovernment efficiency, convenient ticketing and dependable machine-to-machine (M2M) applications.
Gemalto develops secure embedded software and secure products which we design and personalize. Our platforms and services manage these secure products, the confidential data they contain and the trusted end-user services they enable. Our innovations offer more ways for our clients to enhance the convenience and security of people’s digital lives.
Gemalto thrives with the growing number of people using its solutions to interact with the digital and wireless world.
For more information visit www.gemalto.com , www.justaskgemalto.com , blog.gemalto.com , or follow @gemalto on Twitter.
Contact:
Gemalto Media Contacts:
Nicole Smith
North America
+1
512 758 8921
nicole.smith@gemalto.com
or
Kristel
Teyras
Europe, Middle East & Africa
+33 1 55 01 57 89
kristel.teyras@gemalto.com
or
Ellen
Lynch
LPI Communications
+1 (415) 225 2240
ellen@lpicommunications.com
or
Ernesto
Haikewitsch
Latin America
+55 11 51 05 92 20
ernesto.haikewitsch@gemalto.com
or
Yvonne
Lim
Asia Pacific
+65 6317 3730
yvonne.lim@gemalto.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom